Trinity Biotech plc's management team will review the strategic investment and partnership with MiCo Limited. Mr. Aris Kekedjian and Mr. Michael Sung Soo Kim have agreed to join the Trinity Biotech Board of Directors. Michael Sung Soo Kim has a wealth of financial experience, having spent the last 3 decades within international finance across areas such as Asset Management, Real Estate Investments, Robo-Advisory and Wealth Management and held a number of senior executive positions, including CEO of Hyundai Securities.

Most recently, Aris was CEO of Icahn Enterprises. They believe that Aris and Michael will bring new and innovative skill set to the Board. And current directors, Kevin Tansley, Clint Severson and James Merselis will retire from the board upon completion of the transaction.